We are LIVE with the finale of our mini-series! In Episode 4.4 - The AI Adoption Arc, we shift the focus outward to exploring Externally Facing AI Tools.While internal efficiencies are critical, the true competitive advantage in Life Sciences lies in how AI reshapes your customer touchpoints. From personalized HCP engagement to responsive patient support, we unpack how to deploy AI that builds trust rather than just cutting costs.Don’t leave the most visible part of your business in the analog age.#Improzo #LifeSciences #AIAdoption #PharmaTech #CustomerExperience #GenerativeAI #DigitalTransformation
In the latest episode of The Improzone Mini-Series 4.3, we explore the critical shift from legal compliance to technical verification. Key Insight: Treat your third-party AI like an "over-eager intern"—talented, capable, but lacking the judgment to represent your brand without supervision.
In this episode, we unpack:
- The Limits of Questionnaires: Why paper surveys fail to catch GenAI hallucinations.
- Brand vs. Security: Why a secure bot can still be toxic.
- Continuous Validation: Why a one-time pen test is already obsolete.
Join Jane Urban and Nathan Trueblood for a masterclass in AI procurement safety.
#ArtificialIntelligence #PharmaTech #DigitalHealth #RiskManagement #AIEthics #VendorManagement #TechLeadership #EnkryptAI #Improzo
In Part 2 of The AI Adoption Arc, we break down the critical shift to building proprietary LLM agents. Discover the severe security vulnerabilities introduced by prompt injection and data contamination in custom workflows. Learn how to implement use-case specific guardrails to achieve measurable, compliant scale. #AICapability #DigitalTransformation #LifeSciencesTech #ComplianceByDesign #AIStrategy #Improzo #ImprozonePodcast
How do life sciences organizations move from AI buzzwords to business impact?
In this episode of The Improzone, discover how to start small, build trust, and make AI your co-pilot for smarter pharma decisions.Watch now and learn how real innovation begins.
#Improzone #AIInPharma #Improzo #LifeSciencesAI #HealthcareInnovation #AIAdoption #DataDrivenDecisions
Here comes our 3rd podcast of the ImproZone!
Join host Jane Urban and Indy Sawhney (AWS) as this episode speaks directly on the execution of Generative AI in Life Sciences.
We dive into how #GenerativeAI is:
Enhancing human performance in R&D and commercial roles.
Enabling faster, smarter insights across global biopharma operations.
Moving from AI strategy to an actionable execution plan.
Listen now to unlock your next steps in #CommercialTransformation!
#LifeSciences #Biopharma #GenAI #DigitalTransformation #Execution #Improzo #Improzone
New Podcast Episode of The Improzone!
Can AI and privacy coexist in pharma? In this episode, our host Jane Urban talks to Improzo's Abhishek Trigunait and Enkrypt AI's Nathan Trueblood about making responsible AI a reality. We're exploring the future of AI in Lifesciences, focusing on data privacy, compliance, and the power of strategic partnerships.
Watch Now and secure the future of your AI strategy. To know more about us, visit www.improzo.com
#AI #Lifesciences #Biotech #HealthTech #Podcast #Improzone #EnkryptAI #Innovation #Pharma #Improzo
You’re about to enter a new dimension—where AI doesn’t just sit in dashboards, it makes decisions.
Improzo CEO Inderpreet Kambo joins host Jane Urban to talk about building modular, pharma-native AI agents that work where users already are—from Veeva to Salesforce.
Why do most pharma AI programs fail? And how do you go from “insight” to actual impact? Step into The Improzone.
🎧 Listen now.